跳至主要内容
临床试验/EUCTR2010-021814-43-FI
EUCTR2010-021814-43-FI进行中(未招募)不适用

The Safety and Tolerability of Methadone/Naloxone Combination in Opioid Substitution Treatment - NAMEKO

lrich Tacke0 个研究点目标入组 8 人开始时间: 2010年8月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • * opioid dependence
  • * methadone treatment
  • * no changes in methadone dose during the last 10 days
  • * good treatment compliance according to doctor
  • * normal ALAT and AFOS values (increased if double the normal level)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • * severe renal or hepatic failure
  • * acute psychosis
  • * age under 18
  • * pregnancy
  • * legal incompetence
  • * severe somatic disease
  • * chaotic situation in life
  • * medication or disease which is contraindication to study treatment

研究者

发起方
lrich Tacke

相似试验

The Safety and Tolerability of Methadone/Naloxone... | 临床试验